CAS RN: 879127-16-9
Aurora Kinase Inhibitor III
Product Availability
Choose a grade to view its available package options.
8 package records7 with current stock3 grade groups
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20260604 |
10mg / 50mg / 100mg / 250mg |
Out of stock |
5-7 business days | Inquiry |
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20260420 |
1ml |
In stock |
| Inquiry |
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20260609 |
100mg |
In stock |
| Inquiry |
| Batchno.20260224 |
10mg |
In stock |
| Inquiry |
| Batchno.20250511 |
250mg |
In stock |
| Inquiry |
| Batchno.20251230 |
25mg |
In stock |
| Inquiry |
| Batchno.20260628 |
50mg |
In stock |
| Inquiry |
| Batchno.20250719 |
5mg |
In stock |
| Inquiry |
-
Product code:
starshine_CAS879127-16-9
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
879127-16-9 / N-[3-[[4-[3-(trifluoromethyl)anilino]pyrimidin-2-yl]amino]phenyl]cyclopropanecarboxamide
Standard CAS: 879127-16-9
Multi CAS: No
Basic Information
CAS
879127-16-9
Multi CAS
No
Molecular Formula
C21F3H18N5O
Molecular Weight
413.400000
Exact Mass
413.146345
InChI
InChI=1S/C21H18F3N5O/c22-21(23,24)14-3-1-4-15(11-14)26-18-9-10-25-20(29-18)28-17-6-2-5-16(12-17)27-19(30)13-7-8-13/h1-6,9-13H,7-8H2,(H,27,30)(H2,25,26,28,29)
InChIKey
RDTDWGQDFJPTPD-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
30
Aromatic heavy atom count
18
Fraction Csp3
0.19
Rotatable bonds
6
H-bond acceptors
5
H-bond donors
3
Molar refractivity
107.84
TPSA
78.94
LogP / Solubility
WLOGP
5.33
MLOGP
4.72
XLogP3
4.5
Consensus LogP
4.85
Log S (ESOL)
-5.81
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.8
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.49
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.46
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3